A Drug Utilization Study of Radium-223 in Sweden
The objective of this study is to evaluate the extent of potential off-label use of Xofigo in Sweden.
- Patients receiving Xofigo with data recorded at nuclear medicine centers in Sweden between 01 July 2014 and 30 June 2016 will be included in the study
- Patients receiving Xofigo in a clinical trial will not be included in this study
E-mail: [email protected]
Phone: Not Available
A Drug Utilization Study of Xofigo Use in Sweden